MADJACK PUBLIC RELATIONS - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/85099.xml MADJACK PUBLIC RELATIONS - Press Releases en xml@emediawire.com xml@emediawire.com 30 Rosenbaum Faria LLP Follows the Investigation of Mercy Medical Center's Responsibility for Young Woman's Death Following A Double Mastectomy for Cancer Misdiagnosed Due to Lab Mistake http://www.prweb.com/releases/2008/02/prweb700824.htm According to leading New York newspapers, including The Times and Newsday, Mercy Medical Center of Long Island is under investigation for improper care and treatment of patients and improper lab practices. (PRWeb Feb 16, 2008)

Read the full story at http://www.prweb.com/releases/2008/02/prweb700824.htm

]]> http://www.prweb.com/releases/2008/02/prweb700824.htm Rosenbaum Faria, LLP, Finds Latest Medtronic Recall Alarming To Clients Already Reeling From Multiple Defibrillator Recalls http://www.prweb.com/releases/2007/11/prweb565969.htm Rosenbaum Faria, LLP, has discovered this latest recall exceedingly alarming to clients already contending with other heart device-related recalls. Medtronic's October 2007 recall of its Spring Fidelis defibrillator leads is the eighth Class I recall for the heart device manufacturer. (PRWeb Nov 2, 2007)

Read the full story at http://www.prweb.com/releases/2007/11/prweb565969.htm

]]> http://www.prweb.com/releases/2007/11/prweb565969.htm FDA Cites Risks of Roche Laboratories' Rocephin as Rosenbaum Faria LLP Begins Research Into Infant Fatalities from Combination of Calcium and Rocephin http://www.prweb.com/releases/2007/07/prweb539129.htm Manhattan law firm, Rosenbaum Faria, LLP, begins investigating the number of infant deaths associated with Roche Labs' antibiotic treatment Rocephin (ceftriaxone sodium) as the FDA issues updated Dosage and Administration requirements for the drug. The focus of the FDA update is to prevent doctors from administering Rocephin within 48 hours of calcium products to prevent adverse effects including precipitate accumulation in the lungs and kidneys and, for some infants, death. (PRWeb Jul 13, 2007)

Read the full story at http://www.prweb.com/releases/2007/07/prweb539129.htm

]]> http://www.prweb.com/releases/2007/07/prweb539129.htm Rosenbaum Faria, Llp, Reacts To Boston Scientific-Guidant's Latest Recall Of Defective Contak Renewal And Vitality Heart Defibrillator Devices http://www.prweb.com/releases/2007/04/prweb518820.htm Rosenbaum Faria, LLP, a Manhattan lawfirm set to notify clients of the newest round of recalled heart devices. Guidant's Contak Renewal and Vitality models are affected by the new recall based on accelerated battery depletion. (PRWeb Apr 15, 2007)

Read the full story at http://www.prweb.com/releases/2007/04/prweb518820.htm

]]> http://www.prweb.com/releases/2007/04/prweb518820.htm Drug Company Not Allowed To Hide Behind FDA--Baby Boy's Cancer Linked To Novartis Pharmaceutical's Elidel http://www.prweb.com/releases/2006/10/prweb461629.htm US District Court ruling allows parents of cancer victim to proceed in their litigation against Elidel manufacturer Novartis Pharmaceuticals. Novartis' Motion to Dismiss was denied after their argument that FDA labeling regulations prevented their notification of physicians and patients was deemed to be invalid. This landmark decision will have lasting impact on product and drug liability cases throughout the United States where the case relies upon a manufacturer's failure to notify of potential dangers. (PRWeb Oct 27, 2006)

Read the full story at http://www.prweb.com/releases/2006/10/prweb461629.htm

]]> http://www.prweb.com/releases/2006/10/prweb461629.htm FDA Doesn't Receive Additional Safety Study From Bayer About Heart Surgery Medication Trasylol Until After September 2006 Hearings Concluded http://www.prweb.com/releases/2006/10/prweb451553.htm Bayer did not present a critical medical study to the FDA when public hearings were held in September 2006, to review the safety of Bayer's open heart surgery medication Trasylol. (PRWeb Oct 18, 2006)

Read the full story at http://www.prweb.com/releases/2006/10/prweb451553.htm

]]> http://www.prweb.com/releases/2006/10/prweb451553.htm Rosenbaum Faria LLP Prepares to Take on Merck on Behalf of Patients Who Suffered Dead Jaw From Fosamax http://www.prweb.com/releases/2006/09/prweb441987.htm In response to the FDA warnings and reports from more than 2,400 patients that Fosamax and Fosamax Plus D are linked to Dead Jaw Disease, Rosenbaum Faria LLP, a Manhattan-based lawfirm, intends to proceed against pharmaceutical giant Merck. (PRWeb Sep 26, 2006)

Read the full story at http://www.prweb.com/releases/2006/09/prweb441987.htm

]]> http://www.prweb.com/releases/2006/09/prweb441987.htm Martinez, Rosenbaum & Faria LLP Finalize Research and Begin Accepting Cases for Victims of Charite Disc Replacements http://www.prweb.com/releases/2005/11/prweb315257.htm After concluding extensive research into the FDA approval, European cases, and available data, the bicoastal law firm is positioned to accept cases for the victims of possible device failures in people who have had the Johnson & Johnson Charite Artificial Disc Device implanted. (PRWeb Nov 30, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb315257.htm

]]> http://www.prweb.com/releases/2005/11/prweb315257.htm Martinez, Rosenbaum & Faria LLP Support US Attorney in Boston in Quest to Uncover Kickbacks to Doctors by Guidant and Medtronic http://www.prweb.com/releases/2005/11/prweb312393.htm Bicoastal law firm offers support to US Attorney in Boston after subpoenas were issued earlier this week to Guidant, Medtronic, and St. Jude Medical relevant to possible kickbacks paid by the companies to doctors for use of their defibrillators. (PRWeb Nov 19, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb312393.htm

]]> http://www.prweb.com/releases/2005/11/prweb312393.htm Martinez, Rosenbaum & Faria LLP Warns Victims of Defective Heart Devices Not to Cash Checks From Guidant Corporation http://www.prweb.com/releases/2005/11/prweb308397.htm Bicoastal lawfirm warns recipients of checks from Guidant Corporation to speak with a lawyer before cashing the checks. The checks are being issued randomly to recipients of Guidant's failed heart devices. (PRWeb Nov 10, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb308397.htm

]]> http://www.prweb.com/releases/2005/11/prweb308397.htm Martinez, Rosenbaum & Faria LLP Supports NY Attorney General's Lawsuit Against Guidant for Flawed Heart Devices http://www.prweb.com/releases/2005/11/prweb308408.htm Bicoastal lawfirm supports NY Attorney General, Eliot Spitzer's, lawsuit against Guidant Corporation for their failure to disclose faults in their implantable heart defibrillators. (PRWeb Nov 10, 2005)

Read the full story at http://www.prweb.com/releases/2005/11/prweb308408.htm

]]> http://www.prweb.com/releases/2005/11/prweb308408.htm